VA Greater Los Angeles Healthcare System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, VA Greater Los Angeles Healthcare System sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
VA Greater Los Angeles Healthcare System: 23 sponsored US clinical trials, 3 recruiting.
VA Greater Los Angeles Healthcare System sponsors 23 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 18 completed. 7 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Flushing, with 1 trials.
Top-decile sponsor footprint
VA Greater Los Angeles Healthcare System ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
23 total, page 1 of 1
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
NCT07031245
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
NCT06706921
Responsive Neurostimulation for Post-Traumatic Stress Disorder
NCT04152993
Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
NCT06932289
Chronic Care Management With Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy (mPAP) Trial
NCT06039865
Dashboard Activated Services and Tele-Health for Heart Failure
NCT05001165
vEAET for Older Veterans With Chronic Musculoskeletal Pain Pilot
NCT04552860
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer
NCT04390880
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia
NCT03537703
Emotional Awareness and Expression Therapy (EAET) or Cognitive Behavior Therapy (CBT) for Older Veterans With Chronic Musculoskeletal Pain
NCT03844880
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia
NCT02104752
Abobotulinumtoxina Efficacy in Post-Traumatic Headache
NCT03928496
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia
NCT01885338
Pharmacological Approach to Improve the Outcome of Social Cognition Training
NCT01517360
Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?
NCT01312272
Effects of Psyllium on Niacin Tolerability
NCT03370848
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
NCT02476526
Impact of a Novel Patient Educational Booklet on Colonoscopy Quality
NCT00975247
Techniques to Enhance Patient Comfort in Sedation-risk Free Colonoscopy
NCT01076907
A Pilot Clinical Trial Of Memantine for Essential Tremor
NCT00439699
A Safety/Efficacy Trial of Zonisamide for Essential Tremor
NCT00223743
Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD
NCT03370835
Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD
NCT00304421
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 2 |
| Phase 4 | 7 |
What is open in the VA Greater Los Angeles Healthcare System pipeline
3 recruiting of 23 indexed (13% open); 18 completed (78%).
Phase mix: 7 late (III/IV) vs 7 early (I/II) (balanced across stages).
Top condition: Flushing (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
VA Greater Los Angeles Healthcare System: open-pipeline peers nationwide
Peers matched on 23 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
VA Greater Los Angeles Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 trials (± recruiting share)
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- AtriCure · 23 trials · 22% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Food and Drug Administration (FDA) · 13% recruiting · 23 trials
- Loyola University · 13% recruiting · 92 trials
- Intermountain Health Care · 13% recruiting · 85 trials
- MetroHealth Medical Center · 13% recruiting · 76 trials
Related
What to do with this VA Greater Los Angeles Healthcare System page
23 registered trials is a research-attention snapshot, not an endorsement of VA Greater Los Angeles Healthcare System or any single study.
- 3 of VA Greater Los Angeles Healthcare System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Flushing is the condition VA Greater Los Angeles Healthcare System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Flushing trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
VA Greater Los Angeles Healthcare System pipeline card: 23 registered trials from official public datasets.Report a data error.